openPR Logo
Press release

Dr. Rebecca Baillie to Describe PhysioPD™ Model Construction and Testing in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”

06-10-2011 11:28 AM CET | Science & Education

Press release from: Rosa and Co

Rosa Logo

Rosa Logo

Rosa & Co. LLC today announced that Dr. Rebecca Baillie will present a webinar “How to build a PhysioPD model” on June 20, 2011 at 1:00 pm EDT (GMT -5:00) as part of Rosa’s ongoing monthly public webinar series. The purpose of the series, “Impact of Modeling & Simulation in Drug Development”, is to foster the use of Modeling and Simulation (M&S) activities in biotechnology, pharmaceutics, and other life science industries. This series is geared to illustrate the advantages and applicability of M&S in product discovery, development, and marketing programs. Dr. Baillie’s talk, “How to build a PhysioPD model”, will cover the scientific underpinnings of clinically relevant, physiologically-based models with an emphasis on designing these models to address specific uncertainties encountered in pharmaceutical decision-making processes. In particular, Dr. Baillie will discuss how M&S can provide scientific insight and impact program direction prior to the availability of clinical data.

Register for this free webinar at www.rosaandco.com/webinar. After registering, a confirmation email will be sent with directions for joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar.

Rosa informs our customer’s most critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of related issues, Rosa offers two customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these approaches, Rosa’s clients collaborate in model creation and testing, retain the final model, and acquire the ability to use it and understand its implications for their drug development programs. Rosa’s staff have close to two decades of unparalleled professional experience in using drug-disease modeling and simulation (M&S) to accelerate drug development; they have covered hundreds of applications with dozens of clients. The Rosa team is unique in their breadth and depth of disease area experience, which includes metabolic and cardiovascular diseases, oncology, gastro-intestinal disease, inflammatory diseases, immune dysfunction (including rheumatoid arthritis), pain, skin conditions, respiratory disorders, and antibacterials/antivirals. For more information, visit www.rosaandco.com.

751 Laurel St., Ste. 127,
San Carlos, CA 94070

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dr. Rebecca Baillie to Describe PhysioPD™ Model Construction and Testing in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development” here

News-ID: 178863 • Views:

More Releases for Rosa’s

Dr. Arthur Lo, Theravance, to Discuss a Viral Kinetics Model for Optimizing Comp …
Dr. Lo will present the Webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on November 14, 2012. Rosa & Co. LLC today announced that Dr. Arthur Lo, Senior Scientist at Theravance, will present a webinar “Integration of in vitro data into a viral kinetics model to investigate rapid development of Hepatitis C resistance to therapy” on Wednesday, November
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Mus …
Dr. Singh, will present “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” Webinar October 17, 2012. Rosa & Co. LLC today announced that Dr. Pratap Singh, Senior Principal Scientist at Pfizer, will present a webinar “Role of Myostatin in Muscle Growth: Key Learnings From PK/PD Modeling Analysis” on Wednesday, October 17, 2012 at 1:00 - 2:00 pm EDT as part of Rosa’s ongoing monthly public webinar series.
Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa …
Dr. Rowland, will present “Drug development and physiologically based pharmacokinetics” Webinar September 19, 2012 Rosa & Co. LLC today announced that Dr. Malcolm Rowland, Professor Emeritus, University of Manchester, will present a webinar “Addressing drug development questions with physiologically based pharmacokinetics” on Wednesday, September 19, 2012 at 12:00 - 1:00 pm EDT as part of Rosa’s ongoing monthly public webinar series. The purpose of the series, “Impact of Modeling & Simulation
Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, …
Dr. Siler, will present “The DILIsym™ model and its application to hepatotoxicity testing in drug development” Webinar June 19, 2012 Rosa & Co. LLC today announced that Dr. Scott Siler, DILI-sim Consultant, will present a webinar “The DILIsym model and its application to hepatotoxicity testing in drug development” on Tuesday, June 19, 2012 at 1:00 - 2:00 pm EDT as part of Rosa’s ongoing monthly public webinar series. The purpose of
Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar S …
Dr. Gordi, will present “Mechanistic PK/PD Modeling in Pediatrics” Webinar May 22, 2012. Rosa & Co. LLC today announced that Dr. Toufigh Gordi, Rosa & Co, will present a webinar “Mechanistic PK/PD Modeling in Pediatrics” on Tuesday, May 22, 2012 at 1:00 - 2:00 pm EDT as part of Rosa’s ongoing monthly public webinar series. The purpose of the series, “Impact of Modeling & Simulation in Drug Development”, is to foster
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conferenc …
Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced that its Dr. Toufigh Gordi, President of PKPD and Clinical Pharmacology Services, will present the results of an Accelerator Mass Spectrometry (AMS) microdosing study in infants at the 2nd Annual Pediatric Pharmacology Conference in Philadelphia, PA on January 26, 2012. Dr. Gordi will give a 30 minute scientific presentation entitled “Pediatric PK